MedCity News

Penguin Ai Snags $30M to Simplify Prior Auth, Coding and Claims

Goodpath Rakes In $18M for Chronic Condition Platform

Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million.

By Marissa Plescia

BioPharma, Pharma

Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval

Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver disease primary biliary cholangitis. While Ocaliva became an important new treatment option when it won accelerated FDA approval in 2016, PBC patients now have new FDA-approved medicines from Ipsen and Gilead Sciences that don’t pose the same safety risks.

By Frank Vinluan

MedCity Influencers

Health Plan Leaders Reveal Underreported Medicaid Challenges, Anticipated Risks, and Solutions

The coming changes in Medicaid will place health plans squarely between a rock and a hard place. Here's how plans are bracing for change.

By Scott H. Schnell

Latest Video

Latest News

MedCity Influencers

Why Traditional EMRs Are Holding Healthcare Back

Instead of creating new opportunities, traditional EMRs are constraining AI’s potential in healthcare.

By Adam Farren

Events, Artificial Intelligence

Your Guide to the Hottest Topics on AI in Healthcare in Dallas Next Week at INVEST Digital Health

The conference is scheduled for Thursday, September 18 at Pegasus Park in Dallas in partnership with Health Wildcatters. Register today!

By Stephanie Baum

Health Tech

Headway Launches Enhanced EHR Platform for Mental Health Providers

Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability.

By Marissa Plescia

Artificial Intelligence, Startups, Health Tech

Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care

The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care.

By Katie Adams

BioPharma, Pharma

LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M for Key Schizophrenia Drug Trial

LB Pharmaceuticals found enough investor interest to boost the size of its IPO, which will finance clinical trials in schizophrenia and bipolar depression. The biotech has modified an old Sanofi drug with changes intended to reduce side effects and allow less frequent dosing.

By Frank Vinluan

MedCity Influencers

Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination

The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos.

By Brad Kelley

Policy

Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy

The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.

By Stephanie Baum

MedCity Influencers

Overdose treatment abstract concept vector illustration. Group of paramedics deals with patients drug treatment, make injection, medical toxicology, dependence prevention abstract metaphor opioid overdose

Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department

Early diagnostics for acute intoxication in the emergency department are about more than just identifying the cause of an overdose. They can enable timely intervention, reduce the risk of fatal outcomes, and open the door to substance use disorder treatment and recovery

By Jared Jaeger

Startups Artificial Intelligence,

Collage of Business woman surrounded by financial symbols in the city

Positioning & Distribution Will Determine the Winning Healthcare AI Startups, Investor Says

In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workflows are streamlined and value is delivered across stakeholders. This will differentiate winning AI startups from incumbents and copycat competitors, said Morgan Cheatham, head of healthcare and life sciences at Breyer Capital.

By Katie Adams

Consumer / Employer

A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds

Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs.

By Marissa Plescia

BioPharma, Pharma

FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option

A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from the 2019 acquisition of Taris Biomedical.

By Frank Vinluan

MedCity Influencers

The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results

Now is a good time for health systems to step back and ask some foundational questions instead of rushing into their next AI purchase.

By Andy Flanagan

MedCity Influencers

ECG. Сardiograph machine draw heartbeat motion and Dollar sign. Red cardiogram line with graph paper background. Business and money research concept healthcare dinance

Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare

Data is not optional; it is essential to financial stability and strategic growth. The organizations that thrive will be those that use data to lead, not follow.

By Deepali Narula

Health Tech

Strive Health Secures $550M to Advance Value-Based Kidney Care Model

Strive Health's Series D funding was led by New Enterprise Associates, and included participation from CVS Health Ventures, CapitalG, Echo Health and several others.

By Marissa Plescia

Hospitals, Startups Providers,

Portrait of beautiful senior couple on bike ride in autumn nature. Taking break, drinking water from sport bottle and fastening helmet.

Corewell Health Touts Success of Virtual Lifestyle Medicine Program with Nudj Health

Corewell Health is seeing positive results from its partnership with Nudj Health, a startup that delivers virtual lifestyle medicine programs. More than 3,600 Corewell patients have enrolled in Nudj’s programs since 2023 — and their reported improvements include weight loss, reduced depression and anxiety levels, better cholesterol and triglyceride levels, and increased daily exercise minutes.

By Katie Adams